Mitchell Bupp's Independent Voter Radio Debate aired on Freedom Slips on Halloween 2015 -- did you miss it?

The Koch name has become nearly synonymous with GOP 'dark money' and political might. Often portrayed as “bogeyman” by Democrats on the left, these brothers who made their wealth in oil refining have pledged to spend up to $900 million on political advocacy this cycle alone. And since much of that money is funneled through the Koch’s political advocacy nonprofit Americans for Prosperity (which isn't required to report contributions and expenditures), it can be difficult to know just who they are backing.

Prince Charles made worldwide headlines Monday with his claim that climate change had a significant role to play in the root causes of the current Syrian crisis.

Given the near non-stop coverage of the Paris attacks, along with the ISIS propaganda videos that followed and a new attack in Mali, we cannot help but experience anxiety. No one is immune. The threat is real, but how we deal with our emotions is a matter of personal choice.

University of North Texas student body president Adam Alattry recently lamented, "growing up in a Muslim household in the United States, the only Islam I knew was one who preached love, compassion, charity, acceptance and empathy. After Sept. 11, 2001, perceptions of me and my religion were forever changed."

On Wednesday, November 18, Maine Secretary of State Matthew Dunlap certified the petition signatures gathered by The Committee for Ranked Choice Voting (RCV Maine) to put RVC on the 2016 ballot.

A team of bipartisan lawmakers has introduced a bill designed to end what they call "the illegal, counter-productive war to overthrow the Syrian government of Assad."

In September, hedge-fund manager and entrepreneur Martin Shkreli made headlines when he bought the rights to a 62-year-old drug, then raised the price from $13.50 a pill to $750.

And while more Americans are becoming keenly aware of this growing practice--price gouging on existing drugs--where's the outrage?

We typically believe in the free market, where innovation is rewarded, but some of the worst price gouging is occurring in the generic market on very old drugs.

During the Independent Voter Project's 2015 Business and Leadership Conference, experts in the pharmaceutical and medical fields, along with California legislators, participated in a panel discussion on medical innovation up to now and what the future may hold for the industry and patients alike.

At first glance, it would appear that the Golden State has beaten the odds when it comes to creating jobs following the Great Recession. In 2014, the 1.3 million jobs that were lost during the Great Recession were regained and then some, according to the Political Policy Institute of California (PPIC).

Almost weekly, a new headline about Silicon Valley’s booming tech industry reinforces the idea that California’s jobs problem is a thing of the past.